Studieoverzicht

 
 
  2017-02 PERIDENO       Closed       Adjuvant       HER2-, any HR       Postmenopausal  
  2014-03 OLYMPIA       Open       Adjuvant       HER2-, any HR       Both pre- and postmenopausal  
  2014-02 BRAVO       Follow up       Advanced/metastatic       HER2-, any HR       Both pre- and postmenopausal  
  2013-04 DIRECT       Follow up       Neoadjuvant       HER2-, any HR       Both pre- and postmenopausal  
  2010-02 STOP&GO       Follow up       Advanced/metastatic       HER2-, any HR       Both pre- and postmenopausal  
  2010-01 NEO-ZOTAC       Follow up       Neoadjuvant       HER2-, any HR       Both pre- and postmenopausal  
  2006-06 ATX       Closed       Advanced/metastatic       HER2-, any HR       Both pre- and postmenopausal